SARS-CoV-2 Total Antibody EIA
The clarus SARS-CoV-2 Total Antibody EIA is a rapid, high-volume test that can identify previous infection of the novel coronavirus, SARS-CoV-2. This assay will help identify those who have been exposed, and developed antibodies against the virus, and those who have not.
This test creates an opportunity for communities to gain greater clarity regarding true exposure rates. Hospitals can test their healthcare workers, businesses can test their employees, cities can test their first responders, schools and universities can test their professors, teachers, and staff.
Performance
Sensitivity: 91% (95% Ci: 82, 97)
Specificity: 100% (95% CI: 99, 100)
PPV: 100% (95% CI: 94, 100)
NPV: 98% (95% CI: 96, 99)
*Results performed on patients that are 8+ days post symptom onset
Please contact us if you need a specific product, we are meeting many customers’ unique requests.
